SUMMIT THERAPEUTICS PLC
(86627R102)
Funds Reporting Holdings of SUMMIT THERAPEUTICS PLC according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Lansdowne Partners UK LLP | 1,596,666 | $2,020k | Jun 30, 2019 | Aug 13, 2019 | |
Acadian Asset Management LLC | 173,385 | $220k | Jun 30, 2019 | Aug 8, 2019 |